{"id":"https://openalex.org/W4283453585","doi":"https://doi.org/10.1097/jcp.0000000000001562","title":"Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative Users","display_name":"Acute Cognitive Effects of the Dual Orexin Receptor Antagonist Lemborexant Compared With Suvorexant and Zolpidem in Recreational Sedative Users","publication_year":2022,"publication_date":"2022-06-24","ids":{"openalex":"https://openalex.org/W4283453585","doi":"https://doi.org/10.1097/jcp.0000000000001562","pmid":"https://pubmed.ncbi.nlm.nih.gov/35748777","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9257063"},"language":"en","primary_location":{"id":"doi:10.1097/jcp.0000000000001562","doi":"https://doi.org/10.1097/jcp.0000000000001562","is_oa":true,"landing_page_url":"https://doi.org/10.1097/jcp.0000000000001562","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/jcp.0000000000001562","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002542527","display_name":"Ishani Savant Landry","orcid":"https://orcid.org/0000-0002-4865-4754","observed_orcids":["https://orcid.org/0000-0002-4865-4754"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ishani Landry","raw_affiliation_strings":["Formerly Eisai Inc, Nutley, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Formerly Eisai Inc, Nutley, NJ","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059729118","display_name":"Nancy Hall","orcid":"https://orcid.org/0000-0001-9372-6967","observed_orcids":["https://orcid.org/0000-0001-9372-6967"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy Hall","raw_affiliation_strings":["Eisai Inc, Nutley, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc, Nutley, NJ","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059283422","display_name":"Jagadeesh Alur","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jagadeesh Alur","raw_affiliation_strings":["Eisai Inc, Nutley, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc, Nutley, NJ","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042782165","display_name":"Gleb Filippov","orcid":"https://orcid.org/0000-0001-9380-9463","observed_orcids":["https://orcid.org/0000-0001-9380-9463"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gleb Filippov","raw_affiliation_strings":["Formerly Eisai Inc, Nutley, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Formerly Eisai Inc, Nutley, NJ","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064852158","display_name":"Larisa Reyderman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larisa Reyderman","raw_affiliation_strings":["Eisai Inc, Nutley, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc, Nutley, NJ","institution_ids":["https://openalex.org/I4210151718"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076526470","display_name":"Beatrice Setnik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I4210107788","display_name":"Altasciences (Canada)","ror":"https://ror.org/01g6xse81","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210107788"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Beatrice Setnik","raw_affiliation_strings":["Altasciences, Laval, Quebec and the Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Altasciences, Laval, Quebec and the Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750","https://openalex.org/I4210107788"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034406366","display_name":"Jack E. Henningfield","orcid":"https://orcid.org/0000-0001-8387-0041","observed_orcids":["https://orcid.org/0000-0001-8387-0041"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack Henningfield","raw_affiliation_strings":["Pinney Associates, Bethesda, MD, and The Johns Hopkins University School of Medicine, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pinney Associates, Bethesda, MD, and The Johns Hopkins University School of Medicine, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078195357","display_name":"Margaret L. Moline","orcid":"https://orcid.org/0000-0003-0807-2167","observed_orcids":["https://orcid.org/0000-0003-0807-2167"]},"institutions":[{"id":"https://openalex.org/I4210151718","display_name":"Eisai (United States)","ror":"https://ror.org/0469x1750","country_code":"US","type":"company","lineage":["https://openalex.org/I4210151718","https://openalex.org/I55881946"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Margaret Moline","raw_affiliation_strings":["Eisai Inc, Nutley, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eisai Inc, Nutley, NJ","institution_ids":["https://openalex.org/I4210151718"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5078195357"],"corresponding_institution_ids":["https://openalex.org/I4210151718"],"apc_list":null,"apc_paid":null,"fwci":1.2384,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.748782,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"42","issue":"4","first_page":"374","last_page":"382"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.28049999475479126,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.28049999475479126,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11373","display_name":"Sleep and Work-Related Fatigue","score":0.17419999837875366,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.11720000207424164,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lemborexant","display_name":"lemborexant","score":1.0},{"id":"https://openalex.org/keywords/suvorexant","display_name":"suvorexant","score":0.890999972820282},{"id":"https://openalex.org/keywords/zolpidem","display_name":"zolpidem","score":1.0},{"id":"https://openalex.org/keywords/orexin-receptor-antagonists","display_name":"orexin receptor antagonists","score":0.9549999833106995},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.8059999942779541},{"id":"https://openalex.org/keywords/reaction-time","display_name":"reaction time","score":0.8289999961853027},{"id":"https://openalex.org/keywords/divided-attention","display_name":"divided attention","score":0.9860000014305115},{"id":"https://openalex.org/keywords/psychomotor-function","display_name":"psychomotor performance","score":0.7950000166893005},{"id":"https://openalex.org/keywords/supratherapeutic-dose","display_name":"supratherapeutic dose","score":0.7110000252723694},{"id":"https://openalex.org/keywords/hypnotics","display_name":"hypnotics","score":0.4000000059604645}],"concepts":[{"id":"https://openalex.org/C2777602617","wikidata":"https://www.wikidata.org/wiki/Q847705","display_name":"Sedative","level":2,"score":0.5777103304862976},{"id":"https://openalex.org/C2777123777","wikidata":"https://www.wikidata.org/wiki/Q218842","display_name":"Zolpidem","level":3,"score":0.5769612193107605},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5624842047691345},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5570827722549438},{"id":"https://openalex.org/C2777810057","wikidata":"https://www.wikidata.org/wiki/Q220426","display_name":"Zopiclone","level":3,"score":0.5189975500106812},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.44642117619514465},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.4195597171783447},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38772067427635193},{"id":"https://openalex.org/C2780930544","wikidata":"https://www.wikidata.org/wiki/Q62962","display_name":"Hypnotic","level":2,"score":0.1279970109462738},{"id":"https://openalex.org/C2781210498","wikidata":"https://www.wikidata.org/wiki/Q1869874","display_name":"Insomnia","level":2,"score":0.09348157048225403},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068796","descriptor_name":"Orexin Receptor Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000077334","descriptor_name":"Zolpidem","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1097/jcp.0000000000001562","doi":"https://doi.org/10.1097/jcp.0000000000001562","is_oa":true,"landing_page_url":"https://doi.org/10.1097/jcp.0000000000001562","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9257063","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9257063/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9257063/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Clin Psychopharmacol","raw_type":"Text"},{"id":"pmid:35748777","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35748777","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1097/jcp.0000000000001562","doi":"https://doi.org/10.1097/jcp.0000000000001562","is_oa":true,"landing_page_url":"https://doi.org/10.1097/jcp.0000000000001562","pdf_url":null,"source":{"id":"https://openalex.org/S76849566","display_name":"Journal of Clinical Psychopharmacology","issn_l":"0271-0749","issn":["0271-0749","1533-712X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Psychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4283453585.pdf","grobid_xml":"https://content.openalex.org/works/W4283453585.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1640525623","https://openalex.org/W1764050995","https://openalex.org/W1965852413","https://openalex.org/W2006144421","https://openalex.org/W2015441078","https://openalex.org/W2415049614","https://openalex.org/W2420679128","https://openalex.org/W2619950834","https://openalex.org/W2788590302","https://openalex.org/W2892120373","https://openalex.org/W2907565595","https://openalex.org/W2993320799","https://openalex.org/W2998259693","https://openalex.org/W3037971062","https://openalex.org/W3095220730","https://openalex.org/W3096789279","https://openalex.org/W4283459556"],"related_works":["https://openalex.org/W4283459556","https://openalex.org/W2415049614","https://openalex.org/W3017324692","https://openalex.org/W3198121616","https://openalex.org/W3186202283","https://openalex.org/W3202769771","https://openalex.org/W7160421836","https://openalex.org/W1965852413","https://openalex.org/W2001463369","https://openalex.org/W4308493926"],"abstract_inverted_index":{"PURPOSE/BACKGROUND:":[0],"As":[1],"part":[2],"of":[3,10,15,23,44,69,116,256,286],"a":[4,87],"human":[5,82],"abuse":[6,83],"potential":[7,84],"(HAP)":[8],"study":[9,85],"lemborexant":[11],"(LEM),":[12],"the":[13,67,99,103,234,243],"effects":[14,68,232],"therapeutic":[16],"(LEM":[17],"10":[18],"mg),":[19],"and":[20,27,33,41,49,72,108,121,129,159,165,180,197,203,236,259,265],"supratherapeutic":[21,42,284],"doses":[22,43,149,192,211,255,285],"LEM":[24,28,148,166,191,210,276],"20":[25],"mg":[26,30,48],"30":[29,47],"on":[31,76],"cognition":[32],"psychomotor":[34],"performance":[35],"were":[36,58,139,186,240],"compared":[37],"with":[38],"placebo":[39],"(PBO)":[40],"zolpidem":[45],"(ZOL)":[46],"suvorexant":[50],"(SUV)":[51],"40":[52],"mg.":[53],"Subjects":[54],"(n":[55],"=":[56,163],"32)":[57],"healthy,":[59],"nondependent,":[60],"recreational":[61],"sedative":[62],"users":[63],"able":[64],"to":[65,98,242,248,278],"discriminate":[66],"both":[70],"SUV":[71,160,204,260],"ZOL":[73,154,174,198,221,287],"from":[74,133,173],"PBO":[75,145,185],"subjective":[77],"drug":[78],"measures.":[79,290],"METHODS/PROCEDURES:":[80],"The":[81,112],"was":[86,169],"single-dose,":[88],"randomized,":[89],"double-blind,":[90],"PBO-controlled,":[91],"6-way":[92],"crossover":[93],"study.":[94],"Eligible":[95],"subjects":[96],"admitted":[97],"treatment":[100,245],"phase":[101,246],"completed":[102],"choice":[104],"reaction":[105,118,123,127,178,263],"test":[106,239],"(CRT)":[107],"divided":[109,237,267],"attention":[110,238,268],"test.":[111],"CRT":[113,235],"included":[114],"measurements":[115],"recognition":[117],"time":[119,128,179,264],"(RRT)":[120],"motor":[122],"time.":[124],"FINDINGS/RESULTS:":[125],"Recognition":[126],"mean":[130,181,217],"maximum":[131],"change":[132],"baseline":[134],"(CFB":[135],"max":[136,183,219],")":[137],"scores":[138],"significantly":[140,187,213,279],"increased":[141,188,262],"(slower":[142],"performance)":[143,216],"versus":[144,184,220,270],"for":[146,189],"all":[147,190,230],"(all":[150,167,193,222],"P":[151,156,162,194,200,206,223],"<":[152,157,195,201,207,224],"0.001),":[153,158,196,225],"(":[155,161,199,205],"0.004),":[164],"doses)":[168],"not":[170,227],"statistically":[171],"different":[172],"or":[175],"SUV.":[176,228],"Motor":[177],"CFB":[182,218],"0.001)":[202],"0.001).":[208],"All":[209,253],"showed":[212],"decreased":[214],"(better":[215],"but":[226],"Notably,":[229],"cognitive":[231,281],"in":[233,288],"limited":[241],"main":[244],"(up":[247],"8":[249],"hours":[250],"postdose).":[251],"IMPLICATIONS/CONCLUSIONS:":[252],"active":[254],"LEM,":[257],"ZOL,":[258],"generally":[261],"reduced":[266],"capabilities":[269],"PBO.":[271],"However,":[272],"at":[273],"therapeutic/supratherapeutic":[274],"doses,":[275],"led":[277],"less":[280],"impairment":[282],"than":[283],"some":[289]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2022-06-26T00:00:00"}